Skip to main content

Advertisement

Log in

Prognostic Prediction of Oral Squamous Cell Carcinoma by E-Cadherin and N-Cadherin Expression in Overall Cells in Tumor Nests or Tumor Cells at the Invasive Front

  • Original Article
  • Published:
Cancer Microenvironment

Abstract

Epithelial-mesenchymal transition (EMT) is a significant process in the invasion and metastasis of cancers including oral squamous cell carcinoma (OSCC), and the cadherin switch has been identified as one of the hallmarks of EMT. The aim of the present study was to evaluate the significance of the cadherin switch in the prognosis of OSCC and generate a model for prognostic predictions. Seventy-six biopsy and/or initial surgical specimens from OSCC patients were immunohistochemically analyzed for the expression of E-cadherin and N-cadherin in either overall OSCC cells in tumor nests or in OSCC cells at the invasive front. Among 76 OSCC cases, overall OSCC cells in tumor nests were negative for the expression of E-cadherin in 10 cases and positive for that of N-cadherin in 53 cases. Among 10 cases negative for the expression of E-cadherin, 4 cases were positive for that of N-cadherin. In OSCC cells at the invasive front, the expression of E-cadherin was negative in 62 cases, while that of N-cadherin was positive in 39 cases. Among 62 cases negative for the expression of E-cadherin, 33 cases were positive for that of N-cadherin. A logistic regression analysis showed that a model using the evaluation of N-cadherin expression in overall OSCC cells in tumor nests with a cut-off point of 70 years old was the best fit model. These results suggest that N-cadherin has significant value in prognostic predictions for OSCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Neville BW, Damm DD, Allen CM, Bouquot JE (eds) (2009) Oral and maxillofacial pathology, 3rd edn. Saunders, St. Louis, pp 409–421

    Google Scholar 

  2. Chang JS, Lo HI, Wong TY, Huang CC, Lee WT, Tsai ST et al (2013) Investigating the association between oral hygiene and head and neck cancer. Oral Oncol 49:1010–1017

    Article  PubMed  Google Scholar 

  3. Tsai ST, Wong TY, CY O, Fang SY, Chen KC, Hsiao JR et al (2014) The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer. Int J Cancer 135:2424–2436

    Article  CAS  PubMed  Google Scholar 

  4. Barness L, Eveson JW, Reichart P, Sidransky D (eds) (2005) Pathology and genetics of head and neck Tumours. World Health Organization classification of Tumours. IARC Press, Lyon, pp 166–175

    Google Scholar 

  5. Gupta B, Johnson NW (2014) Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One 9:e113385

    Article  PubMed  PubMed Central  Google Scholar 

  6. Marur S, Forastiere AA (2016) Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc 91:386–396

    Article  PubMed  Google Scholar 

  7. Malik UU, Zarina S, Pennington SR (2016) Oral squamous cell carcinoma: key clinical questions, biomarker discovery, and the role of proteomics. Arch Oral Biol 63:53–65

    Article  CAS  PubMed  Google Scholar 

  8. Vigneswaran N, Williams MD (2014) Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am 26:123–141

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hunter KD, Parkinson EK, Harrison PR (2005) Profiling early head and neck cancer. Nat Rev Cancer 5:127–135

    Article  CAS  PubMed  Google Scholar 

  10. Scully C, Bagan J (2009) Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis 15:388–399

    Article  CAS  PubMed  Google Scholar 

  11. Katsuno Y, Lamouille S, Derynck R (2013) TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 25:76–84

    Article  CAS  PubMed  Google Scholar 

  12. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

    Article  CAS  PubMed  Google Scholar 

  14. Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415–428

    Article  CAS  PubMed  Google Scholar 

  15. Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J et al (2009) A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 11:943–950

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Moustakas A, Heldin CH (2012) Induction of epithelial-mesenchymal transition by transforming growth factor beta. Semin Cancer Biol 22:446–454

    Article  CAS  PubMed  Google Scholar 

  17. Xu J, Lamouille S, Derynck R (2009) TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19:156–172

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Ikushima H, Miyazono K (2010) TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 10:415–424

    Article  CAS  PubMed  Google Scholar 

  19. Smith A, Teknos TN, Pan Q (2013) Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol 49:287–292

    Article  PubMed  Google Scholar 

  20. Scanlon CS, Van Tubergen EA, Inglehart RC, D'Silva NJ (2013) Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res 92:114–121

    Article  CAS  PubMed  Google Scholar 

  21. Krisanaprakornkit S, Iamaroon A (2012) Epithelial-mesenchymal transition in oral squamous cell carcinoma. ISRN Oncol 2012:681469

  22. Luo SL, Xie YG, Li Z, Ma JH, Xu X (2014) E-cadherin expression and prognosis of oral cancer: a meta-analysis. Tumour Biol 35:5533–5537

    Article  CAS  PubMed  Google Scholar 

  23. Ren X, Wang J, Lin X, Wang X (2016) E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations. Onco Targets Ther 9:2447–2453

    Article  PubMed  PubMed Central  Google Scholar 

  24. da Silva SD, Morand GB, Alobaid FA, Hier MP, Mlynarek AM, Alaoui-Jamali MA et al (2015) Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clin Exp Metastasis 32:55–63

    Article  PubMed  Google Scholar 

  25. Fan CC, Wang TY, Cheng YA, Jiang SS, Cheng CW, Lee AY et al (2013) Expression of E-cadherin, twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma. J Cancer Res Clin Oncol 139:1735–1744

    Article  CAS  PubMed  Google Scholar 

  26. Tanaka N, Odajima T, Ogi K, Ikeda T, Satoh M (2003) Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer 89:557–563

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Zhao D, Tang XF, Yang K, Liu JY, Ma XR (2012) Over-expression of integrin-linked kinase correlates with aberrant expression of snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis. Clin Exp Metastasis 29:957–969

    Article  CAS  PubMed  Google Scholar 

  28. Pectasides E, Rampias T, Sasaki C, Perisanidis C, Kouloulias V, Burtness B et al (2014) Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC). PLoS One 9:e94273

    Article  PubMed  PubMed Central  Google Scholar 

  29. DID M, Pierantoni GM, Feola A, Esposito F, Laino L, DER A et al (2011) Prognostic significance of N-cadherin expression in oral squamous cell carcinoma. Anticancer Res 31:4211–4218

    Google Scholar 

  30. Nguyen PT, Kudo Y, Yoshida M, Kamata N, Ogawa I, Takata T (2011) N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition. Histol Histopathol 26:147–156

    CAS  PubMed  Google Scholar 

  31. Yang TL, CT W, Ko JY, Wang CP, Lou PJ, Chang YL (2011) Significance of tumor satellite variables in reflecting the epithelial-mesenchymal transition of tongue cancer. Oral Oncol 47:720–724

    Article  CAS  PubMed  Google Scholar 

  32. Soares MQ, Mendonca JA, Morais MO, Leles CR, Batista AC, Mendonca EF (2015) E-cadherin, beta-catenin, and alpha2beta1 and alpha3beta1 integrin expression in primary oral squamous cell carcinoma and its regional metastasis. Histol Histopathol 30:1213–1222

    CAS  PubMed  Google Scholar 

  33. Seki S, Fujiwara M, Matsuura M, Fujita S, Ikeda H, Asahina I et al (2011) Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors. Oral Oncol 47:588–593

    Article  CAS  PubMed  Google Scholar 

  34. Seki S, Fujiwara M, Matsuura M, Fujita S, Ikeda H, Umeda M et al (2014) Prognostic value of podoplanin expression in oral squamous cell carcinoma--a regression model auxiliary to UICC classification. Pathol Oncol Res 20:521–528

    Article  CAS  PubMed  Google Scholar 

  35. Lindenblatt Rde C, Martinez GL, Silva LE, Faria PS, Camisasca DR, Lourenco Sde Q (2012) Oral squamous cell carcinoma grading systems--analysis of the best survival predictor. J Oral Pathol Med 41:34–39

    Article  PubMed  Google Scholar 

  36. Akaike H (1973) Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F (eds) Proceeding of the second international symposium on information theory, Budapest, p 267–281

  37. Ukpo OC, Thorstad WL, Zhang Q, Lewis JS Jr (2012) Lack of association of cadherin expression and histopathologic type, metastasis, or patient outcome in oropharyngeal squamous cell carcinoma: a tissue microarray study. Head Neck Pathol 6:38–47

    Article  CAS  PubMed  Google Scholar 

  38. Hanemann JA, Oliveira DT, Nonogaki S, Nishimoto IN, de Carli ML, Landman G et al (2014) Expression of E-cadherin and beta-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers? BMC Cancer 14:395

    Article  PubMed  PubMed Central  Google Scholar 

  39. Balasundaram P, Singh MK, Dinda AK, Thakar A, Yadav R (2014) Study of beta-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases. Diagn Pathol 9:145

    Article  PubMed  PubMed Central  Google Scholar 

  40. Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275–292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E (2009) Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 11:1287–1296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Friedl P, Gilmour D (2009) Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10:445–457

    Article  CAS  PubMed  Google Scholar 

  43. Hashimoto T, Soeno Y, Maeda G, Taya Y, Aoba T, Nasu M et al (2012) Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch. PLoS One 7:e47899

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Costa LC, Leite CF, Cardoso SV, Loyola AM, Faria PR, Souza PE et al (2015) Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma. J Appl Oral Sci 23:169–178

    Article  PubMed  PubMed Central  Google Scholar 

  45. Angadi PV, Patil PV, Angadi V, Mane D, Shekar S, Hallikerimath S et al (2016) Immunoexpression of epithelial mesenchymal transition proteins E-cadherin, beta-catenin, and N-cadherin in oral squamous cell carcinoma. Int J Surg Pathol 24:696–703

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tohru Ikeda.

Ethics declarations

Conflict of Interest

The authors declare that they have no potential conflicts of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee, and with the 1964 Declaration of Helsinki and its latter amendments or comparable ethical standards. Nagasaki University Hospital Ethics Committee Approval No.: 17,022,746.

Informed Consent

Written informed consent was not used and information regarding this study was disclosed on the website of Nagasaki University Clinical Research Center and assured the right for refusal to use samples and clinical information. Some of the subjects were already passed away and refusal by the proxy of the subject was also permitted.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ozaki-Honda, Y., Seki, S., Fujiwara, M. et al. Prognostic Prediction of Oral Squamous Cell Carcinoma by E-Cadherin and N-Cadherin Expression in Overall Cells in Tumor Nests or Tumor Cells at the Invasive Front. Cancer Microenvironment 10, 87–94 (2017). https://doi.org/10.1007/s12307-017-0201-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12307-017-0201-1

Keywords

Navigation